Roche Holding AG

Type: Company
Name: Roche Holding AG (Roche Holding Ltd)
Nationality: Switzerland
Web Address: http://www.roche.com/
Fact Sheet: Fact Sheet for Roche Holding AG
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Roche again ranked most sustainable healthcare company in the Dow Jones Sustainability Indices

For the sixth consecutive year, Roche has been recognised by the Dow Jones Sustainability Indices (DJSI) as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry. This places Roche amongst the top 10 percent ... [Published Dubai PR Network - 12 hours ago]
First reported 16 hours ago - Updated 16 hours ago - 1 reports

Novartis continues its successful injunction spree

Novartis AG holds the patent for the drug containing the active pharmaceutical ingredients vildagliptin and vildagliptin in combination with metformin hydrochloride (Indian Patent 212815), which it had sold under the Galvus and Galvus-Met brands in India ... [Published Intellectual Asset Management - 16 hours ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

A risk that yielded rich rewards in Kerala

Comment · print · T TT+· T-In October 1999, when two young IT professionals in Thiruvananthapuram decided to chuck their job at a reputed company and strike out on their own, it was a proposition fraught with risks. That was a time when words like ... [Published The Hindu - 17 hours ago]
First reported Sep 19 2014 - Updated Sep 19 2014 - 2 reports

Global Transcriptomics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and Thermo Fisher Scientific

/PRNewswire/ --Research and Markets  ( http://www.researchandmarkets.com/research/j8jfz4/global ) has announced the addition of the  "Global Transcriptomics Market 2014-2018"  report to their offering.Transcriptomics studies involve the collection and ... [Published CW Atlanta - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Research and Markets: Genomics Market in the US 2014-2018: Key Vendors Dominating are Bio-Rad Labs, F. Hoffman-La Roche, Illumina, Qiagen & Thermo Fisher Scientific

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/smwl46/genomics_market) has announced the addition of the "Genomics Market in the US 2014-2018" report to their offering. The Genomics market in the US to grow at ... [Published Business Wire Health News - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

ImmunoGen, Inc. Hires Sandra E. Poole as Senior Vice President of Technical Operations

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops targeted anticancer therapies using its antibody-drug conjugate (ADC) technology, today announced the appointment of Sandra E. Poole as Senior Vice ... [Published FierceBiotech - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Roche's $8 billion InterMune Buy Not a Sign of More Big Deals

The decision by Swiss drugmaker Roche in August to buy US biotech company InterMune for $8.3 billion was "exceptional" and not a sign of more ambitious plans for major acquisitions, the Swiss drugmaker's chief executive, Severin Schwan, said in an interview ... [Published CHEManager - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 2 reports

Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer

/PRNewswire/ --Research and Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular ) has announced the addition of the "Global Molecular Cytogenetics Market 2014-2018" report to their offering.Identification and validation of the ... [Published WorldNetDaily - Sep 19 2014]
First reported Sep 16 2014 - Updated Sep 17 2014 - 4 reports

Global Hepatitis C Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Gilead, Johnson & Johnson, Merck and Vertex Pharmaceuticals

Nearly 20 percent of infected individuals develop jaundice, which is characterized by the yellowing of skin and eyes. Nearly 15-45 percent of acutely infected individuals recover from the infection spontaneously within the first six months of infection. ... [Published Indianapolis Business Journal - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 17 2014 - 4 reports

Why Roche (RHHBY) Stock Is Up Today

NEW YORK (TheStreet) -- Shares of Roche Holding are up 1.38% to $37.47 on heavy trading volume after CEO Severin Schwan told Reuters that the company'sadecision to buy U.S. biotech company InterMuneafor $8.3 billion last month was "exceptional" and not ... [Published The Street Latest - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 5 reports

Switzerland takes on its top drugmakers in price row

Roche and Novartis are finding no immunity in Switzerland from a European-wide price squeeze, as reported Yahoo!News Tuesday. The Swiss pharmaceutical industry is responsible for 40 000 jobs and had sales worth more than 66 billion Swiss francs ($70.5 ... [Published FirstWord Pharma - Sep 16 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 3 reports

BHI to work with Roche

BioHealth Innovation Inc., of Rockville, an organization focused on commercializing bio-health innovations and increasing access to early-stage funding in Maryland, announced on Monday an agreement with Roche Pharma Research and Early Development to advance ... [Published Maryland Daily Record - Sep 15 2014]

Quotes

When I first read the PR by the company and saw this statement, "ACT cautions that the improvement in the patient's vision reported in the press release may not be indicative of future results of clinical trials of the RPE cells derived from hESCs" I wondered why is this patient so different? We now know the difference but, the bottom line is, with limited data, we just don't know what caused the...
...The director in charge further says: "Affluent patients from across the globe are willing to travel to find the best hospitals and healthcare facilities. The UAE offers a world-class service in terms of availability and quality, and is easily accessible to the rest of the world thanks to its airline and airport infrastructure. The Dubai Health Care City is providing a platform for increased medical tourism and will bring more revenue to Dubai and the UAE, driving market growth at a much faster rate than historically."
"It could be bigger," Aberman said, "because we believe we're getting at the crux of all these diseases" linked to allergies
...12 research note. "Trends are still early and unclear, although Zydelig scripts have been at less than a third of what Imbruvica was."

More Content

All (1927) | News (1587) | Reports (1) | Blogs (285) | Audio/Video (1) | Fact Sheets (27) | Press Releases (21)
sort by: Date | Relevance
New medications are making inroads in cancer ba... [Published Minneapolis Star Tribune - 5 hours ago]
The richest people on the planet [Published Kazinform - 6 hours ago]
A Repudiation Of Advance Cell Technology's 'Whi... [Published Seeking Alpha - 9 hours ago]
Roche again ranked most sustainable healthcare ... [Published Dubai PR Network - 12 hours ago]
Follow-up of Blood-Pressure Lowering and Glucos... [Published New England Journal of Medicine - 16 hours ago]
Novartis continues its successful injunction spree [Published Intellectual Asset Management - 16 hours ago]
A risk that yielded rich rewards in Kerala [Published The Hindu - 17 hours ago]
ReportsnReports Releases Report on UAE Pharmace... [Published Insurance News Net - 19 hours ago]
China hands GSK record $489m fine for paying br... [Published Qatar Peninsula - Sep 19 2014]
Global Transcriptomics Market 2014-2018: Key Ve... [Published CW Atlanta - Sep 19 2014]
Global Transcriptomics Market 2014-2018: Key Ve... [Published PR Newswire: General Business - Sep 19 2014]
Regeneron says allergy drug may be darling of i... [Published KFGO News - Sep 19 2014]
Evotec takes up legal arms after Andromeda fallout [Published Fierce CRO - Sep 19 2014]
New melanoma treatment approved by NICE [Published Pharmaceutical Journal - Sep 19 2014]
Gilead's Zydelig Approved In EU; Imbruvica In W... [Published Investor's Business Daily - Sep 19 2014]
PDL BioPharma Lifted to “Outperform” at Zacks (... [Published American Banking News - Sep 19 2014]
Incyte: Increasing Sales, Deep Pipeline, Multip... [Published Seeking Alpha - Sep 19 2014]
We need an ecosystem of innovation to retain ou... [Published Hindu Business Line - Sep 19 2014]
Spain's pharma community has made necessary adj... [Published Pharma Letter - Sep 19 2014]
Research and Markets: Genomics Market in the US... [Published Business Wire Health News - Sep 19 2014]
Pharmacists are advised to store Buscopan and b... [Published Pharmaceutical Journal - Sep 19 2014]
Best Relative Performance in the Pharmaceutical... [Published Comtex SmarTrend - Sep 19 2014]
ImmunoGen, Inc. Hires Sandra E. Poole as Senior... [Published FierceBiotech - Sep 19 2014]
Nektar Presents Positive Preclinical Data on Or... [Published Nasdaq - Sep 19 2014]
Nektar Presents Positive Preclinical Data on Or... [Published Good Day Sacramento - Sep 19 2014]
NICE fast-tracks GSK's skin cancer drug Tafinlar [Published PMLive - Sep 19 2014]
Horizon Discovery "well placed" for growth with... [Published Proactive Investors.co.uk - Sep 19 2014]
Horizon Discovery at the forefront of personal ... [Published Proactiveinvestors United Kingdom RSS feed - Sep 19 2014]
Code42 CEO Matthew Dornquast Named a 2014 Titan... [Published Scottrade - Sep 19 2014]
Roche's $8 billion InterMune Buy Not a Sign of ... [Published CHEManager - Sep 19 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Global Transcriptomics Market 2014-2018: Key Ve... [Published PR Newswire: General Business - Sep 19 2014]
DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/j8jfz4/global) has announced the addition of the "Global Transcriptomics Market 2014-2018" report to their offering.      (Logo:... ...
Research and Markets: Genomics Market in the US... [Published Business Wire Health News - Sep 19 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/smwl46/genomics_market) has announced the addition of the "Genomics Market in the US 2014-2018" report to their offering. The Genomics market in the US to grow at ...
Global Molecular Cytogenetics Market 2014-2018:... [Published PR Newswire: General Business - Sep 19 2014]
DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/qqjrnh/global_molecular) has announced the addition of the "Global Molecular Cytogenetics Market 2014-2018" report to their offering.     (Logo:... ...
Global Hepatitis C Market 2014-2018: Key Vendor... [Published PR Newswire: General Business - Sep 17 2014]
DUBLIN, Sept. 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Hepatitis C Market 2014-2018" report to their offering. Hepatitis C is a liver disease caused by infection due to hepatitis C virus. Hepatitis C ...
Global Breast Cancer Market 2014-2018: Key Vend... [Published PR Newswire: General Business - Sep 17 2014]
DUBLIN, Sept. 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Breast Cancer Market 2014-2018" report to their offering. Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Roche to pay $1.7bn for Seragon [Published Reuters Video: Business - Jul 02 2014]
1

Press Releases

sort by: Date | Relevance
Biotech Advancements in Innovative Cancer Thera... [Published Financial Services - Sep 04 2014]
INTERMUNE SHAREHOLDER ALERT: The Law Offices of... [Published GlobeNewswire: Acquisitions News - Sep 03 2014]
Seragon Pharmaceuticals Inc. Announces Closing ... [Published GlobeNewswire: Acquisitions News - Aug 27 2014]
SHAREHOLDER ALERT: Pomerantz LLP Investigates C... [Published Financial Services - Aug 25 2014]
INVESTOR ALERT - InterMune, Inc.: The Law Offic... [Published Financial Services - Aug 25 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.